言語を選択

MOG

MOG 詳細

英語名	Myelin-oligodendrocyte glycoprotein	市販薬剤の数	0
治験薬の数	1	ターゲットの別称	NRCLP7，Myelin-oligodendrocyte glycoprotein，MOG，Myelin Oligodendrocyte Glycoprotein，MOG Ig-AluB，MOG Alpha-5，MOG AluA，MOG AluB，BTNL11，MOGIG2，BTN6
研究＆開発段階	Phase 2 Clinical

英語名	Myelin-oligodendrocyte glycoprotein
ターゲットの別称	NRCLP7，Myelin-oligodendrocyte glycoprotein，MOG，Myelin Oligodendrocyte Glycoprotein，MOG Ig-AluB，MOG Alpha-5，MOG AluA，MOG AluB，BTNL11，MOGIG2，BTN6
市販薬剤の数	0
治験薬の数	1
研究＆開発段階	Phase 2 Clinical

MOG 製品リスト

属性
Protein (3)
製品ライブラリ
オンライン (3)
種
Human (2)Mouse (1)
タグ
His Tag (1)His Tag & Avi Tag (2)
マーカー
Unconjugated (1)Biotin-labeled (2)

製品番号	種	発現システム	製品説明
HOT MOG-H82E5	Human	HEK293	Biotinylated Human MOG Protein, His,Avitag™ (MALS verified)
MOG-H52H3	Human	HEK293	Human MOG Protein, His Tag, low endotoxin
MOG-M82E7	Mouse	HEK293	Biotinylated Mouse MOG Protein, His,Avitag™ (MALS verified)

総数量3

MOGバックグランド

Myelin oligodendrocyte glycoprotein (MOG), is a single-pass transmembrane glycoprotein of the immunoglobulin (Ig) superfamily. MOG is a myelin protein exclusively expressed in the CNS at the outermost surface of myelin sheaths and oligodendrocyte membranes. This makes MOG a potential target of cellular and humoral immune responses in inflammatory demyelinating diseases. Due to its late postnatal developmental expression, MOG is an important marker for oligodendrocyte maturation.